Animal vaccine for MERS might be the best approach, experts say

09/12/2013 | Canada.com

It might be more advantageous for scientists to produce a Middle East respiratory syndrome coronavirus vaccine for animals suspected to be part of the human transmission chain rather than develop a human vaccine, according to some infectious disease specialists. The cost and time involved in obtaining regulatory approval are limiting factors for human vaccine development, while animal vaccine development is more time- and cost-effective. Animal vaccines are an underused way to protect people from zoonotic disease, says physician Tom Monath, a founder of the One Health Initiative.

View Full Article in:

Canada.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT